New Cancer Therapy Target May Disrupt Shared Resources Among Tumor Cells
CD133 widely recognized as a cancer stem cell marker associated with drug resistance and cancer relapse, has recently been the focus of a study published in the international journal eLife titled “IdentificationRead More…